Primary |
Reflux Oesophagitis |
18.0% |
Hypertension |
15.5% |
Gastric Ulcer |
11.6% |
Helicobacter Infection |
8.1% |
Gastritis |
6.6% |
Diabetes Mellitus |
4.1% |
Rheumatoid Arthritis |
4.1% |
Duodenal Ulcer |
3.5% |
Insomnia |
3.1% |
Atrial Fibrillation |
2.9% |
Gastric Ulcer Helicobacter |
2.9% |
Schizophrenia |
2.7% |
Hyperlipidaemia |
2.5% |
Osteoporosis |
2.5% |
Constipation |
2.3% |
Gastrooesophageal Reflux Disease |
2.3% |
Cardiac Failure Chronic |
1.9% |
Myocardial Infarction |
1.9% |
Gastric Ulcer Haemorrhage |
1.7% |
Gastrointestinal Haemorrhage |
1.7% |
|
Interstitial Lung Disease |
13.5% |
Rhabdomyolysis |
13.5% |
Hepatic Function Abnormal |
7.5% |
Colitis Collagenous |
6.0% |
Liver Disorder |
6.0% |
White Blood Cell Count Decreased |
6.0% |
Toxic Epidermal Necrolysis |
5.3% |
Loss Of Consciousness |
4.5% |
Blood Creatine Phosphokinase Increased |
3.8% |
Jaundice |
3.8% |
Drug Eruption |
3.0% |
Electrocardiogram Qt Prolonged |
3.0% |
Gastric Ulcer Haemorrhage |
3.0% |
Hypokalaemia |
3.0% |
Oculomucocutaneous Syndrome |
3.0% |
Pneumonia |
3.0% |
Road Traffic Accident |
3.0% |
Stevens-johnson Syndrome |
3.0% |
Tenderness |
3.0% |
Thrombocytopenia |
3.0% |
|
Secondary |
Product Used For Unknown Indication |
16.3% |
Helicobacter Infection |
11.7% |
Drug Use For Unknown Indication |
10.8% |
Hypertension |
9.6% |
Gastrooesophageal Reflux Disease |
8.4% |
Gastric Ulcer |
6.7% |
Rheumatoid Arthritis |
6.3% |
Prophylaxis |
5.0% |
Ill-defined Disorder |
3.6% |
Reflux Oesophagitis |
3.1% |
Hyperlipidaemia |
2.3% |
Diabetes Mellitus |
2.2% |
Duodenal Ulcer |
2.2% |
Insomnia |
1.9% |
Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
Angina Pectoris |
1.8% |
Constipation |
1.6% |
Dyspepsia |
1.6% |
Gastritis |
1.6% |
Pneumonia |
1.5% |
|
Hepatic Function Abnormal |
10.1% |
Toxic Epidermal Necrolysis |
9.4% |
Interstitial Lung Disease |
8.8% |
White Blood Cell Count Decreased |
8.2% |
Liver Disorder |
6.9% |
Stevens-johnson Syndrome |
6.3% |
Pancytopenia |
5.7% |
Pyrexia |
5.7% |
Gamma-glutamyltransferase Increased |
5.0% |
Subclavian Artery Stenosis |
5.0% |
Face Oedema |
3.8% |
Renal Impairment |
3.8% |
Rhabdomyolysis |
3.1% |
Sudden Hearing Loss |
3.1% |
Bone Marrow Failure |
2.5% |
Drug Reaction With Eosinophilia And Systemic Symptoms |
2.5% |
Hyperkalaemia |
2.5% |
Lymphocyte Stimulation Test Positive |
2.5% |
Urticaria |
2.5% |
White Blood Cell Count Increased |
2.5% |
|
Concomitant |
Prophylaxis |
15.7% |
Hypertension |
12.6% |
Rheumatoid Arthritis |
11.2% |
Drug Use For Unknown Indication |
10.2% |
Product Used For Unknown Indication |
8.2% |
Constipation |
4.2% |
Diabetes Mellitus |
4.2% |
Insomnia |
4.0% |
Gastritis |
4.0% |
Gastric Ulcer |
3.4% |
Cancer Pain |
3.3% |
Multiple Myeloma |
2.5% |
Pain |
2.4% |
Chronic Hepatitis C |
2.4% |
Osteoporosis |
2.2% |
Metastatic Renal Cell Carcinoma |
2.0% |
Reflux Oesophagitis |
1.9% |
Hepatic Neoplasm Malignant |
1.9% |
Pneumonia |
1.8% |
Asthma |
1.7% |
|
White Blood Cell Count Decreased |
14.3% |
Interstitial Lung Disease |
7.8% |
Renal Impairment |
7.0% |
Platelet Count Decreased |
6.4% |
Thrombocytopenia |
6.3% |
Pyrexia |
5.8% |
Vomiting |
5.6% |
Sepsis |
5.0% |
Pneumonia |
4.7% |
Respiratory Failure |
4.7% |
Hepatic Function Abnormal |
4.3% |
White Blood Cell Count Increased |
4.3% |
Rash |
3.5% |
Pneumocystis Jiroveci Pneumonia |
3.2% |
Liver Disorder |
3.1% |
Shock |
3.1% |
Renal Failure Acute |
3.0% |
Stomatitis |
3.0% |
Neutrophil Count Decreased |
2.6% |
Renal Failure |
2.6% |
|
Interacting |
Hypertension |
20.7% |
Reflux Oesophagitis |
20.7% |
Myocardial Infarction |
17.2% |
Osteoporosis |
13.8% |
Gastric Ulcer |
6.9% |
Gastritis |
6.9% |
Hypercholesterolaemia |
6.9% |
Hyperlipidaemia |
3.4% |
Ulcer |
3.4% |
|
Platelet Count Decreased |
57.1% |
Feeling Abnormal |
14.3% |
Renal Disorder |
14.3% |
Road Traffic Accident |
14.3% |
|